TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.

Lawrence N Shulman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.